Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $118.3000 (1.09%) ($116.0900 - $118.3100) on Fri. Feb. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.59% (three month average) | RSI | 62 | Latest Price | $118.3000(1.09%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 0.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(43%) IBB(42%) XBI(41%) VFMO(39%) VT(39%) | Factors Impacting UTHR price | UTHR will decline at least -0.795% in a week (0% probabilities). VXX(-13%) TLT(-13%) VIXM(-10%) UUP(-10%) XHB(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.795% (StdDev 1.59%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $118.32(-0.02%) | 10 Day Moving Average | $118.02(0.24%) | 20 Day Moving Average | $117.12(1.01%) | To recent high | -1.1% | To recent low | 16.7% | Market Cap | $5.247b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |